Drug manufacturer Bausch Health announced it will exempt all Arkansas providers and pharmacies from its 340B contract pharmacy policy, including [...] …
Category: Providers
As part of a report on incentivizing use of accountable care organizations (ACOs), Congress’ primary research arm recently recommended excluding [...] …
Attorneys for both covered entities and drug manufacturers say they expect a significant number of filings to the newly re-established [...] …
The state agency tasked with implementing Maine’s state 340B hospital reporting requirement has proposed a rule with additional data and [...] …
Thousands of covered entities that purchased more than one hundred Novartis products between late 2019 and early 2023 will be [...] …
Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...] …
Sen. John Thune (R-S.D.), who is spearheading a major bipartisan 340B reform package, told hospital executives Tuesday that 340B legislation [...] …
Virginia Senate Democrats yesterday narrowly voted to reject Gov. Glenn Youngkin’s (R) proposed amendment to a 340B contract pharmacy access [...] …
The Missouri House overwhelmingly passed a bill this week to bar drugmaker 340B contract pharmacy restrictions, but it could face [...] …
Federal regulators recently said any decision on whether to provide Medicare Advantage (MA) plans funds to reimburse hospitals for past [...] …